首页> 外文期刊>Tumori. >Overall and disease-free survival greater than 12 years in metastatic non-small cell lung cancer after linear accelerator-based stereotactic radiosurgery for solitary brain metastasis.
【24h】

Overall and disease-free survival greater than 12 years in metastatic non-small cell lung cancer after linear accelerator-based stereotactic radiosurgery for solitary brain metastasis.

机译:基于直线加速器的立体定向放射外科手术治疗孤立性脑转移后,转移性非小细胞肺癌的总体生存期和无病生存期均超过12年。

获取原文
获取原文并翻译 | 示例
           

摘要

The best treatment approach for solitary brain metastasis is not well defined and there is no consensus on this issue. It is still being debated whether patients with isolated brain metastasis should undergo surgical resection or stereotactic radiosurgery, and which patients should receive adjuvant whole brain radiotherapy. The median survival in patients with single or multiple metastatic lesions who underwent only stereotactic radiosurgery improved from two-three months to nine months. To the best of our knowledge this is the first report on patients treated with linear accelerator-based stereotactic radiosurgery alone where an overall survival of more than 12 years was obtained, maintaining good quality of life in three cases of solitary brain metastasis from non-small cell lung cancer. In addition to the case reports, we present a brief literature review on this topic.
机译:孤立性脑转移的最佳治疗方法尚不明确,在这个问题上尚无共识。患有孤立性脑转移的患者是否应该进行手术切除或立体定向放射外科手术,以及哪些患者应接受辅助全脑放射治疗仍在争论中。仅接受立体定向放射外科手术的单个或多个转移性病变患者的中位生存期从2个月提高到9个月。据我们所知,这是首例仅使用基于线性加速器的立体定向放射外科手术治疗的患者的报告,该患者的总生存期超过12年,在3例非小脑转移患者中保持了良好的生活质量细胞肺癌。除了案例报告,我们还提供有关该主题的简短文献综述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号